Bluejay Diagnostics, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 0.5403 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.41M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Details
| Name | Bluejay Diagnostics, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 6 |
| Founded | 2015 |
| Ipo Date | 2021-11-10 |
| Ceo | Indranil Dey |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 10.00 |
| Isin | US0956336087 |
| Cusip | 095633608 |
| Cik | 1704287 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Indranil Dey | Principal Financial, Accounting and Executive Officer, President, Chief Executive Officer and Director |
| Kevin Vance | Chief Commercial Officer |
| Mark W. Feinberg M.D., Ph.D. | Chief Medical Advisor |
| Dr. Mark W. Feinberg M.D. | Chief Medical Advisor |
Contact
| Address | 360 Massachusetts Avenue, Suite 203, Acton, Massachusetts 01720, United States |
| Phone | 844 327 7078 |
| Website | https://bluejaydx.com |